Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity SONIC HEALTHCARE LIMITED
ABN | 24 004 196 909 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Christopher David Wilks |
Date of last notice | 17 September 2019 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct and Indirect |
Nature of indirect interest | Ordinary shares in Sonic Healthcare Limited are held in the name |
(including registered holder) | of Hot Clothing Company Pty Ltd |
Note: Provide details of the circumstances | |
giving rise to the relevant interest. | Ordinary shares in Sonic Healthcare Limited are held in the Sonic |
Healthcare Employee Share Trust ("SHEST") | |
Date of change | 17 September 2019, 18 September 2019 and 23 September 2019 |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
No. of securities held prior to change
Direct
685,735 Sonic Healthcare Limited ordinary shares
101,633 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2015, expiring 20 November 2020; exercisable at $19.41 each under the Sonic Healthcare Limited Employee Option Plan having satisfied performance criteria
206,430 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2016 and will vest on 17 November 2019, subject to performance criteria over period 1 July 2016 to 30 June 2019; exercisable at $21.62 each under the Sonic Healthcare Limited Employee Option Plan
27,021 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2016 and will vest on 17 November 2019, subject to performance criteria over period 1 July 2016 to 30 June 2019, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan
207,678 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020; exercisable at $21.64 each under the Sonic Healthcare Limited Employee Option Plan
26,996 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan
205,415 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021; exercisable at $21.69 each under the Sonic Healthcare Limited Employee Option Plan
26,934 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan
Indirect
73,000 Sonic Healthcare Limited ordinary shares held by Hot Clothing Company Pty Ltd
12,190 Sonic Healthcare Limited ordinary shares held by CPU Share Plans Pty Limited atf SHEST
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 | 01/01/2011 |
Appendix 3Y | |||
Change of Director's Interest Notice | |||
Class | Fully paid ordinary shares in Sonic Healthcare Limited | ||
Number acquired | Nil | ||
Number disposed | Forfeited: | ||
∙ 133,323 unlisted options over ordinary shares in Sonic | |||
Healthcare Limited with an exercise price of $21.62 each | |||
under the Sonic Healthcare Limited Employee Option Plan; | |||
and | |||
∙ 17,451 unlisted performance rights over ordinary shares in | |||
Sonic Healthcare Limited with Nil exercise price under the | |||
Sonic Healthcare Limited Performance Rights Plan | |||
as a result of not meeting the long-term incentive performance | |||
conditions over the measurement period from 1 July 2016 to 30 | |||
June 2019. | |||
∙ Sold 120,000 ordinary shares in Sonic Healthcare Limited | |||
to fund the recent exercise of options. | |||
Value/Consideration | $27.932 per share on the sale of ordinary shares. | ||
Note: If consideration is non‐cash, provide | |||
details and estimated valuation | |||
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3
Appendix 3Y
Change of Director's Interest Notice
No. of securities held after change
Direct
565,735 Sonic Healthcare Limited ordinary shares
101,633 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2015, expiring 20 November 2020; exercisable at $19.41 each under the Sonic Healthcare Limited Employee Option Plan having satisfied performance criteria
73,107 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2016, expiring 17 November 2021; exercisable at $21.62 each under the Sonic Healthcare Limited Employee Option Plan, which will vest in November 2019, having satisfied performance criteria
9,570 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2016 which will vest in November 2019 having satisfied performance criteria with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan
207,678 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020; exercisable at $21.64 each under the Sonic Healthcare Limited Employee Option Plan
26,996 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan
205,415 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021; exercisable at $21.69 each under the Sonic Healthcare Limited Employee Option Plan
26,934 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan
Indirect
73,000 Sonic Healthcare Limited ordinary shares held by Hot Clothing Company Pty Ltd
12,190 Sonic Healthcare Limited ordinary shares held by CPU Share Plans Pty Limited atf SHEST
Nature of change
Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back
- On 17 September 2019 and 18 September 2019, on-market sale of shares (120,000 shares in total) to fund the recent exercise of options.
- 133,323 options and 17,451 rights forfeited on 23 September 2019 in accordance with the terms of the options and performance rights grants.
+ See chapter 19 for defined terms.
Appendix 3Y Page 4 | 01/01/2011 |
Appendix 3Y
Change of Director's Interest Notice
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non‐cash, provide details and an estimated valuation
Interest after change
Part 3 - +Closed period
Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Sonic Healthcare Limited published this content on 23 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2019 06:56:02 UTC